Ralph Schulz

477 total citations
9 papers, 119 citations indexed

About

Ralph Schulz is a scholar working on Immunology, Genetics and Molecular Biology. According to data from OpenAlex, Ralph Schulz has authored 9 papers receiving a total of 119 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 6 papers in Genetics and 1 paper in Molecular Biology. Recurrent topics in Ralph Schulz's work include Chronic Lymphocytic Leukemia Research (6 papers), Immune Cell Function and Interaction (4 papers) and T-cell and B-cell Immunology (3 papers). Ralph Schulz is often cited by papers focused on Chronic Lymphocytic Leukemia Research (6 papers), Immune Cell Function and Interaction (4 papers) and T-cell and B-cell Immunology (3 papers). Ralph Schulz collaborates with scholars based in Germany, Spain and Czechia. Ralph Schulz's co-authors include Martina Seiffert, Dolors Colomer, Bola S. Hanna, Peter Lichter, Philipp M. Roessner, Stephan Stilgenbauer, M Körbling, B Dörken, Antonio Pezzutto and S Cayeux and has published in prestigious journals such as Blood, Scientific Reports and British Journal of Haematology.

In The Last Decade

Ralph Schulz

8 papers receiving 118 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ralph Schulz Germany 5 66 59 37 36 35 9 119
Brittney Dienes United States 3 53 0.8× 36 0.6× 29 0.8× 20 0.6× 36 1.0× 11 89
Andrew Keezer United States 6 77 1.2× 137 2.3× 22 0.6× 47 1.3× 117 3.3× 14 160
Rosalie de Beaumont United States 3 43 0.7× 19 0.3× 51 1.4× 10 0.3× 34 1.0× 3 104
Johan A. Dobber Netherlands 5 51 0.8× 94 1.6× 53 1.4× 33 0.9× 52 1.5× 7 125
Erica B. Bhavsar United States 3 39 0.6× 78 1.3× 22 0.6× 19 0.5× 61 1.7× 11 118
Zachary A. Hing United States 3 30 0.5× 62 1.1× 18 0.5× 33 0.9× 50 1.4× 5 103
Marina Deodato Italy 6 22 0.3× 75 1.3× 15 0.4× 18 0.5× 53 1.5× 13 99
Jennie Zhang United States 6 16 0.2× 79 1.3× 21 0.6× 50 1.4× 50 1.4× 13 103
С. В. Семочкин Russia 5 15 0.2× 44 0.7× 32 0.9× 44 1.2× 33 0.9× 35 94
Ory Rouvio Israel 7 20 0.3× 38 0.6× 51 1.4× 71 2.0× 14 0.4× 19 126

Countries citing papers authored by Ralph Schulz

Since Specialization
Citations

This map shows the geographic impact of Ralph Schulz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralph Schulz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralph Schulz more than expected).

Fields of papers citing papers by Ralph Schulz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ralph Schulz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralph Schulz. The network helps show where Ralph Schulz may publish in the future.

Co-authorship network of co-authors of Ralph Schulz

This figure shows the co-authorship network connecting the top 25 collaborators of Ralph Schulz. A scholar is included among the top collaborators of Ralph Schulz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ralph Schulz. Ralph Schulz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Hanna, Bola S., Philipp M. Roessner, Ralph Schulz, et al.. (2020). Combining ibrutinib and checkpoint blockade improves CD8+ T-cell function and control of chronic lymphocytic leukemia in Em-TCL1 mice. Haematologica. 106(4). 968–977. 31 indexed citations
2.
Schulz, Ralph, Morihiro Higashi, Marta Aymerich, et al.. (2019). Targeting IRAK4 disrupts inflammatory pathways and delays tumor development in chronic lymphocytic leukemia. Leukemia. 34(1). 100–114. 38 indexed citations
3.
Roessner, Philipp M., Bola S. Hanna, Selcen Öztürk, et al.. (2019). TBET‐expressing Th1 CD4+T cells accumulate in chronic lymphocytic leukaemia without affecting disease progression in Eµ‐TCL1 mice. British Journal of Haematology. 189(1). 133–145. 13 indexed citations
4.
Schulz, Ralph, Midoriko Higashi, Marta Aymerich, et al.. (2019). PS1144 TARGETING IRAK4 DISRUPTS INFLAMMATORY PATHWAYS AND DELAYS TUMOR DEVELOPMENT IN CHRONIC LYMPHOCYTIC LEUKEMIA. HemaSphere. 3(S1). 518–518. 1 indexed citations
5.
Yakoub, Abraam M., et al.. (2018). Autoantigen-Harboring Apoptotic Cells Hijack the Coinhibitory Pathway of T Cell Activation. Scientific Reports. 8(1). 10533–10533. 4 indexed citations
6.
Rosich, Laia, Ralph Schulz, Morihiro Higashi, et al.. (2018). Targeting IRAK4 Disrupts Inflammatory Pathways and Delays Tumor Development in Chronic Lymphocytic Leukemia. Blood. 132(Supplement 1). 2650–2650. 1 indexed citations
7.
Haderk, Franziska, Laura Llaó Cid, Murat Iskar, et al.. (2016). CLL Exosome-Derived Y RNA hY4 Induces TLR7/8-Mediated Inflammation and PD-L1 Expression in Monocytes. Blood. 128(22). 3217–3217. 1 indexed citations
8.
9.
Herz, A., Ralph Schulz, & Michael Wüster. (1982). Development of selective tolerance to particular types of opiate receptors.. PubMed. 41. 215–22.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brittney Dienes Breakdown of academic impact, for papers by Andrew Keezer Breakdown of academic impact, for papers by Rosalie de Beaumont Breakdown of academic impact, for papers by Johan A. Dobber Breakdown of academic impact, for papers by Erica B. Bhavsar Breakdown of academic impact, for papers by Zachary A. Hing Breakdown of academic impact, for papers by Marina Deodato Breakdown of academic impact, for papers by Jennie Zhang Breakdown of academic impact, for papers by С. В. Семочкин Breakdown of academic impact, for papers by Ory Rouvio
Rankless by CCL
2026